Dr.Sezer Sağlam (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation

Professional Experience

Prof. Dr. Sağlam has held various significant positions throughout his career:

• Current Position: Clinical Oncologist at Gayrettepe Florence Nightingale Hospital, Istanbul
• Previous Roles:
  • Medical Oncologist at Metropolitan Florence Nightingale Hospital, Istanbul (1999–2001)
  • Physician at Bayraktar Dialysis Center, Istanbul (1997–1998)

Academic Contributions

Prof. Dr. Sağlam is actively involved in academic and research activities:

• Conducted studies on gastrointestinal cancers
• Developed a patented method to reduce chemotherapy toxicity
• Participated in clinical trials and observational studies related to oncology

Areas of Expertise

Prof. Dr. Sağlam specializes in the treatment of various cancers, with a patient-centric approach:

• Gastrointestinal Cancers: Including stomach, colon, and rectal cancers
• Breast Cancer: Comprehensive treatment plans tailored to individual needs
• Pancreatic Cancer: Utilizing advanced chemotherapy protocols
• Prostate and Lung Cancers: Offering both chemotherapy and immunotherapy options

Publications and Research

Prof. Dr. Sağlam has contributed to numerous peer-reviewed journals, highlighting his research acumen:

• Topuz E, Eralp Y, Sağlam S, et al. “Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer.” Gynecologic Oncology. 2004;92(1):147–5.
• Balci NC, Akun E, Erturk M, Sağlam S, et al. “Renal-related perinephric fluid collections: MRI findings.” Magnetic Resonance Imaging. 2005;23(5):679–84.
• Basaran M, Bavbek ES, Sağlam S, et al. “A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.” Oncology. 2007;72(3–4):255–60.

Patient Care Philosophy

Prof. Dr. Sağlam emphasizes a holistic approach to patient care:

• Prioritizes clear communication and patient education
• Offers online consultations for international patients
• Focuses on reducing treatment side effects to improve quality of life
• Developed the “LIP method” for treating leptomeningeal metastases, enhancing patient outcomes

Professional Affiliations

Prof. Dr. Sağlam is affiliated with several esteemed medical organizations:

• Turkish Medical Oncology Association
• European Neuroendocrine Tumor Society (ENETS)
• European Society of Medical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)

FAQs

Is Dr. Sezer Sağlam board-certified?

Yes, Prof. Dr. Sağlam is board-certified in medical oncology.

What types of treatments does he offer?

He provides chemotherapy and immunotherapy for various cancers, including gastrointestinal, breast, pancreatic, prostate, and lung cancers.

Does he treat international patients?

Yes, he offers online consultations and treatment plans for international patients.

How long is the typical hospital stay for chemotherapy?

The duration varies based on the treatment protocol, but many chemotherapy sessions are administered on an outpatient basis.

What languages does he speak?

Prof. Dr. Sağlam is fluent in English and Turkish.

Has he received any notable awards?

Yes, he was nominated for the International Best Researcher Award in 2024 for his research on hepatocellular carcinoma in liver-transplanted patients.